Collaborative study of pharmacoepidemiology toward personalized medicine for non-communicable diseases
| Project/Area Number |
16H07201
|
|---|
| Research Category |
Grant-in-Aid for Research Activity Start-up
|
| Allocation Type | Single-year Grants |
|---|
| Research Field |
Epidemiology and preventive medicine
|
|---|
| Research Institution | Showa Pharmaceutical University |
|---|
Principal Investigator |
|
|---|
| Project Period (FY) |
2016-08-26 – 2018-03-31
|
| Project Status |
Completed (Fiscal Year 2017)
|
| Budget Amount *help |
¥2,860,000 (Direct Cost: ¥2,200,000、Indirect Cost: ¥660,000)
Fiscal Year 2017: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2016: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
|
|---|
| Keywords | 薬剤疫学研究 / コホート研究 / 薬剤疫学 / 薬学 |
|---|
| Outline of Final Research Achievements |
In this study, we investigated whether the variation in genes involved in lipid metabolism modify the effect of the 3-hydroxymethyl-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors on serum low density lipoprotein cholesterol concentration reduction, using the information from treating physicians and pharmacies, laboratory assessments and genomic data in the Rotterdam Study in the Netherlands, a prospective population-based cohort study that aims to study the frequency and determinants of diseases in middle-aged and elderly individuals,.
We also verified the pharmacoepidemiological data from a longitudinal cohort study in Japan.
|
Report
(3 results)
Research Products
(4 results)
